Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Biomarkers in long COVID-19: A systematic review. Front Med (Lausanne). 2023 Jan Pasini E, Corsetti G, Romano C, Scarabelli TM, Chen-Scarabelli C, Saravolatz L, Dioguardi FS. Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications. Front Med (Lausanne). 2021 Jul Klein, J., Wood, J., Jaycox, J.R. et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139–148 (2023). Shilia Jacob Kurian, Sara Poikayil Mathews, Abin Paul, Subeesh K. Viswam, Shivashankara Kaniyoor Nagri, Sonal Sekhar Miraj, Shubhada Karanth, Association of serum ferritin with severity and clinical outcome in COVID-19 patients: An observational study in a tertiary healthcare facility,Clinical Epidemiology and Global Health,Volume 21,2023 Tsilingiris D, Vallianou NG, Karampela I, Christodoulatos GS, Papavasileiou G, Petropoulou D, Magkos F, Dalamaga M. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. Int J Mol Sci. 2023 Jun Conti, V.; Corbi, G.; Sabbatino, F.; De Pascale, D.; Sellitto, C.; Stefanelli, B.; Bertini, N.; De Simone, M.; Liguori, L.; Di Paola, I.; et al. Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches. J. Pers. Med. 2023, 13 , 334. Patel, M.A., Knauer, M.J., Nicholson, M. et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med 28, 122 (2022)

Long Haul COVID-19 Treatment

March 23, 2021

Long-Haul COVID-19, also known as Post-Acute Sequelae of SARS-CoV-2 (PASC), can cause lingering symptoms that affect daily life. At Text2MD, Dr. Miguel Antonatos, a board-certified internal medicine physician, specializes in treating Long-Haul COVID patients through personalized telemedicine care. Our goal is to help you manage persistent symptoms and improve your quality of life.

Long Haul COVID-19 Symptoms

Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), can present a range of symptoms that persist or emerge after the acute phase of the infection. Common long haul symptoms include:

Fatigue
Shortness of breath or difficulty breathing
Chest pain or tightness
Joint or muscle pain
Difficulty concentrating or “brain fog”
Sleep disturbances
Heart palpitations
Prolonged loss of taste or smell
Headaches
Dizziness when standing (orthostatic hypotension)
Depression or anxiety
Worsening of pre-existing chronic conditions

These symptoms can last for weeks or even months after recovering from the initial COVID-19 infection. The severity and duration vary from person to person.

How Dr. Antonatos Can Help

Miguel Antonatos MD

I’m a physician specializing in internal medicine with over 15 years of experience working in hospitals, particularly focused on treating chronic inflammatory and metabolic conditions. Throughout my career, I’ve had the opportunity to work in various health systems across the U.S. and, since the start of the COVID-19 pandemic, I’ve been privileged to help numerous patients in the U.S., Europe, and Latin America who are dealing with the long-term effects of COVID-19.

My involvement with COVID-19 began in 2020 when I started to explore the latest research on how the virus (SARS-CoV-2) affects the body and to use existing drugs in new ways to combat the virus. My research and collaboration with global experts has covered how the virus interacts with the body’s systems, including how it can lead to blood vessel inflammation, blood clots, activation of immune cells, persistent viral presence, and imbalance in the body’s mitochondrial function and the microbiome. My approach to treatment is customized for each person, avoiding one-size-fits-all methods, understanding different COVID Long haul phenotypes is essential to direct an effective treatment.

What makes my approach unique is my focus on treating the whole person, not just the illness. While I do use medications, I prioritize natural and comprehensive methods, ensuring that treatment supports overall health and wellness. This deep commitment to the personal well-being of my patients is at the heart of my practice, setting my approach apart from more conventional treatments.

Affiliations

Featured Appearances

Dr. Been – Interview with Dr. Antonatos on COVID Management

SolveME -Dr. Antonatos Discussion on Long Covid Technology Panel: Solve Long Covid Initiative & The Global Interdependence Center

Cytokine Testing & Inflammation Management

Understand Your Immune Response with Cytokine Testing

Cytokine testing helps identify immune dysregulation in Long-Haul COVID patients. Elevated inflammatory markers may contribute to symptoms like fatigue, brain fog, and joint pain. Through advanced lab testing, we assess cytokine levels to guide personalized treatment plans

*Due to State Laws Laboratory Blood Work is NOT Available in NJ and NY

References
1. Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Biomarkers in long COVID-19: A systematic review. Front Med (Lausanne). 2023 Jan
2. Pasini E, Corsetti G, Romano C, Scarabelli TM, Chen-Scarabelli C, Saravolatz L, Dioguardi FS. Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications. Front Med (Lausanne). 2021 Jul
3. Klein, J., Wood, J., Jaycox, J.R. et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139–148 (2023).
4. Shilia Jacob Kurian, Sara Poikayil Mathews, Abin Paul, Subeesh K. Viswam, Shivashankara Kaniyoor Nagri, Sonal Sekhar Miraj, Shubhada Karanth,
  Association of serum ferritin with severity and clinical outcome in COVID-19 patients: An observational study in a tertiary healthcare facility,Clinical Epidemiology and Global Health,Volume 21,2023
5. Tsilingiris D, Vallianou NG, Karampela I, Christodoulatos GS, Papavasileiou G, Petropoulou D, Magkos F, Dalamaga M. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. Int J Mol Sci. 2023 Jun
6. Conti, V.; Corbi, G.; Sabbatino, F.; De Pascale, D.; Sellitto, C.; Stefanelli, B.; Bertini, N.; De Simone, M.; Liguori, L.; Di Paola, I.; et al. Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches. J. Pers. Med. 2023, 13, 334.
7. Patel, M.A., Knauer, M.J., Nicholson, M. et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med 28, 122 (2022)